Product Code: 978-1-68038-875-6
Continuous Glucose Monitoring Devices Market Growth & Trends:
The global continuous glucose monitoring devices market size is anticipated to reach USD 7.51 billion by 2030 and it is projected to grow at a CAGR of 7.19% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing cases of diabetes and introduction of novel and advanced diabetes care and management devices are the major factors driving the market growth. Continuous glucose monitoring (CGM) devices provide an efficient method to measure body glucose levels in real time. Data recorded by these devices is transmitted through a wireless network to receivers; this helps keep track of glucose levels over a designated period.
With the advent of digital therapeutics, a rising number of continuous glucose monitoring devices are being incorporated with apps and software to help patients with diabetes mellitus. Apps such as Glucose buddy, Diabetes Connect, MySugar, and others are available under paid subscription. Further, the rise in the number of diabetes mellitus has contributed significantly toward the global market growth. The device allows real time biofeedback and behavioral change support, allowing effective management of diabetes by the patient. Additionally, the government is spending a huge amount on diabetic care tools to closely monitor diabetes in patient. For instance, according to American Diabetes Association, the overall cost of diagnosed diabetes in the United States for the year 2022 is estimated to be USD 412.9 billion. This amount encompasses direct medical costs of USD 306.6 billion and indirect costs of USD 106.3 billion associated with diabetes.
Diabetes management demands intensive efforts to maintain normal glucose levels and reduce complications, decrease healthcare expenditures, & prevent premature death. This involves monitoring blood sugar levels, taking insulin, following a proper diet, and regular exercising. However, the current sensor technology used to monitor glucose levels only works with a "one-size-fits-all" approach, which does not cater to the special needs of subpopulations such as senior citizens, ethnic minorities, children, adolescents, and people with limited resources. To rectify this, future diabetes technology must be adaptable to diverse users. The ideal devices should be customizable, user-friendly, and affordable. These devices can also be combined with behavioral interventions to promote patient- & family-centered care and provide decision-support tools for clinicians. Although there have been significant advancements in CGM technology, its widespread use is still limited by biological, pharmacological, and socioeconomic factors. Aforementioned factors suggests continuous glucose monitoring devices market growth in the near future.
Continuous Glucose Monitoring Device Market Report Highlights:
- Based on the component, the sensors segment led the market in 2023 with the largest revenue share of 40.66%, owing to technological advancements in the sensor technology such as development of smaller, more accurate, and longer-lasting sensors, which has made them more comfortable and convenient for users
- Based on the connectivity, the Bluetooth segments led the market with the largest revenue share of 59.6% in 2023. Bluetooth chip-enabled sensors are growing rapidly in the CGM market due to their ability to seamlessly transmit data to a connected device
- Based on the end-use, the homecare segment is expected to grow at a fastest CAGR of 7.73% and projected to maintain its dominance over the forecast period
- North America dominated the market with a revenue share in 2023, attributed to wide adoption of CGM devices along with the increasing prevalence of diabetes disorder in the region
- The Europe continuous glucose monitoring devices market holds the second largest market share in 2023 and expected to grow at a significant CAGR in the forecast period. The increasing awareness about the benefits of CGM devices, such as real-time monitoring of glucose levels, early detection of hypoglycemia and hyperglycemia, and reduction in HbA1c levels, is driving the demand for CGM devices in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Component
- 1.2.2. Connectivity
- 1.2.3. End-use
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.5.1.1. Approach 1: Commodity flow approach
- 1.5.1.2. Approach 2: Country wise market estimation using bottom up approach.
- 1.6. Data Validation & Publishing
- 1.7. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Snapshot
- 2.3. Competitive Insights Snapshot
Chapter 3. Market Variables, Trends, and Scope
- 3.1. Market Lineage
- 3.1.1. Parent Market Analysis
- 3.1.2. Ancillary Market Analysis
- 3.2. Continuous Glucose Monitoring Devices Market - Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of diabetes
- 3.2.1.2. Rising geriatric population
- 3.2.1.3. Rising adoption of Continuous Glucose Monitoring (CGM) devices and technological advancements
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of CGM devices and lack of reimbursement policies
- 3.3. Business Environmental Tools Analysis: Continuous Glucose Monitoring Devices Market
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTLE Analysis
- 3.4. Pricing Analysis
Chapter 4. Continuous Glucose Monitoring Devices Market: Component Estimates & Trend Analysis
- 4.1. Continuous Glucose Monitoring Devices market, by Component: Key Takeaways
- 4.2. Continuous Glucose Monitoring Devices Market: Component Movement Analysis
- 4.3. Transmitters
- 4.3.1. Transmitters Market, 2018 - 2030 (USD Million)
- 4.4. Sensors
- 4.4.1. Sensors Market, 2018 - 2030 (USD Million)
- 4.5. Receivers
- 4.5.1. Receivers Market, 2018 - 2030 (USD Million)
Chapter 5. Continuous Glucose Monitoring Devices Market: Connectivity Estimates & Trend Analysis
- 5.1. Continuous Glucose Monitoring Devices market, by Connectivity: Key Takeaways
- 5.2. Continuous Glucose Monitoring Devices Market: Connectivity Movement Analysis
- 5.3. Bluetooth
- 5.3.1. Bluetooth Market, 2018 - 2030 (USD Million)
- 5.4. 4G
- 5.4.1. 4G Market, 2018 - 2030 (USD Million)
Chapter 6. Continuous Glucose Monitoring Devices Market: End-use Estimates & Trend Analysis
- 6.1. Continuous Glucose Monitoring Devices Market, by End-use: Key Takeaways
- 6.2. Continuous Glucose Monitoring Devices Market: End-use Movement Analysis
- 6.3. Hospitals
- 6.3.1. Hospitals market, 2018 - 2030 (USD Million)
- 6.4. Home Care Settings
- 6.4.1. Home Care Settings Market, 2018 - 2030 (USD Million)
- 6.5. Others
- 6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Continuous Glucose Monitoring Devices Market: Regional Estimates & Trend Analysis
- 7.1. Continuous Glucose Monitoring Devices Market: Regional Movement Analysis, 2023 & 2030
- 7.2. North America
- 7.2.1. North America Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Product Benchmarking
- 7.2.2.4. Regulatory Framework
- 7.2.2.5. Reimbursement Structure
- 7.2.2.6. U.S. Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Product Benchmarking
- 7.2.3.4. Regulatory Framework
- 7.2.3.5. Reimbursement Structure
- 7.2.3.6. Canada Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Product Benchmarking
- 7.3.2.4. Regulatory Framework
- 7.3.2.5. Reimbursement Structure
- 7.3.2.6. UK Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Product Benchmarking
- 7.3.3.4. Regulatory Framework
- 7.3.3.5. Reimbursement Structure
- 7.3.3.6. Germany Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Product Benchmarking
- 7.3.4.4. Regulatory Framework
- 7.3.4.5. Reimbursement Structure
- 7.3.4.6. France Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Product Benchmarking
- 7.3.5.4. Regulatory Framework
- 7.3.5.5. Reimbursement Structure
- 7.3.5.6. Italy Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Product Benchmarking
- 7.3.6.4. Regulatory Framework
- 7.3.6.5. Reimbursement Structure
- 7.3.6.6. Spain Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Product Benchmarking
- 7.3.7.4. Regulatory Framework
- 7.3.7.5. Reimbursement Structure
- 7.3.7.6. Denmark Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Product Benchmarking
- 7.3.8.4. Regulatory Framework
- 7.3.8.5. Reimbursement Structure
- 7.3.8.6. Sweden Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Product Benchmarking
- 7.3.9.4. Regulatory Framework
- 7.3.9.5. Reimbursement Structure
- 7.3.9.6. Norway Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Regulatory Framework
- 7.4.2.5. Reimbursement Structure
- 7.4.2.6. Japan Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Regulatory Framework
- 7.4.3.5. Reimbursement Structure
- 7.4.3.6. China Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Regulatory Framework
- 7.4.4.5. Reimbursement Structure
- 7.4.4.6. India Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Regulatory Framework
- 7.4.5.5. Reimbursement Structure
- 7.4.5.6. Australia Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Regulatory Framework
- 7.4.6.5. Reimbursement Structure
- 7.4.6.6. Thailand Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Regulatory Framework
- 7.4.7.5. Reimbursement Structure
- 7.4.7.6. South Korea Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Regulatory Framework
- 7.5.2.5. Reimbursement Structure
- 7.5.2.6. Brazil Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Regulatory Framework
- 7.5.3.5. Reimbursement Structure
- 7.5.3.6. Mexico Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. Argentina
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Regulatory Framework
- 7.5.4.5. Reimbursement Structure
- 7.5.4.6. Argentina Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East & Africa
- 7.6.1. Middle East & Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Product Benchmarking
- 7.6.2.4. Regulatory Framework
- 7.6.2.5. Reimbursement Structure
- 7.6.2.6. South Africa Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Product Benchmarking
- 7.6.3.4. Regulatory Framework
- 7.6.3.5. Reimbursement Structure
- 7.6.3.6. Saudi Arabia Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Product Benchmarking
- 7.6.4.4. Regulatory Framework
- 7.6.4.5. Reimbursement Structure
- 7.6.4.6. UAE Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Product Benchmarking
- 7.6.5.4. Regulatory Framework
- 7.6.5.5. Reimbursement Structure
- 7.6.5.6. Kuwait Continuous Glucose Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participants Overview
- 8.2. Company Categorization
- 8.2.1. Market Leaders
- 8.2.2. Company Market Share Analysis, 2023
- 8.3. Financial Performance
- 8.4. Company Profiles
- 8.4.1. Dexcom, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.1.3. Type Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Abbott
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.2.3. Type Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Medtronic
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.3.3. Type Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Ypsomed AG
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.4.3. Type Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Senseonics Holdings, Inc.
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.5.3. Type Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. A. Menarini Diagnostics S.r.l.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.6.3. Type Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Signos, Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 8.4.7.3. Type Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Acquisition
- 8.5.3. Collaborations
- 8.5.4. Type/Service Launch
- 8.5.5. Partnerships
- 8.5.6. Others
Chapter 9. KOL Recommendations/Analyst Perspective